About Sanyou Biopharmaceuticals
Sanyou Biopharmaceuticals Co., Ltd. is a global leader in the research, development, and service of innovative biologic drugs. The company has developed the 4C business model, integrating “Differentiated CRO, Integrated CDO, Innovative CPO, and Characteristic CRS,” with the mission of simplifying the R&D process for innovative biologics. Sanyou operates a state-of-the-art biologic drug R&D laboratory, supported by a highly skilled team, most of whom hold advanced degrees (Ph.D. or Master’s). The company boasts three industry-leading technology platforms—Super-Trillion, Integration, and Intelligence—comprising over 50 sub-platforms. These include Sanyou’s core Super-Trillion Phage Display Platform and others that support biologics discovery, molecular optimization, preclinical R&D, and industrial-scale development.
As the company continues to grow, Sanyou remains committed to the operational strategy of “platform, project, responsibility, process, standardization, and refinement.” By embracing advanced international management models and establishing a robust R&D quality management system, Sanyou is well-positioned to offer increasingly valuable services to its clients and partners. Recognizing the importance of digital transformation, Sanyou seeks to enhance collaboration, automation, and integration within its R&D operations, ultimately accelerating business innovation.
Challenges & Needs
Prior to partnering with Neotrident, Sanyou had already adopted digital R&D management systems such as an Electronic Lab Notebook (ELN). However, as Sanyou’s business expanded, new challenges and requirements emerged:
- Evolving R&D Needs: As drug research and development processes advanced, Sanyou’s existing ELN system, designed for traditional experimental data management, became insufficient. Without continuous updates, the system could not keep pace with the evolving needs of the business.
- Complex Project Management: With the increasing number of projects, a single ELN system was no longer capable of managing complex R&D projects. Sanyou required a unified platform that could integrate multiple systems and modules to manage the entire drug development process more effectively.
- Flexible Data Management: Due to the nature of biological experiments, Sanyou needed an ELN that could handle a large number of Excel files and manage sample submissions for inspection. Researchers required a system that offered flexible, user-friendly functionality.
Our Solutions
After evaluating various options, Sanyou Biopharmaceuticals selected Neotrident’s SaaS-based iLabPower ELN to replace their locally deployed ELN system. Simultaneously, they implemented the iLabPower PM project management system to complement the ELN. The implementation process was completed in less than two weeks, with the system fully operational shortly thereafter.
The Director of Sanyou Biopharmaceuticals’ QA department stated:
“The iLabPower platform has a simple, user-friendly interface and performs smoothly, which has been appreciated by our team. The SaaS-based deployment allows for rapid product iteration, greatly improving agility. Neotrident regularly sends their professional teams to discuss our technical needs, ensuring they understand our business requirements. The combination of cloud deployment and localized technical support has been highly efficient.”
Results & Benefits
Through its partnership with Neotrident, Sanyou Biopharmaceuticals has enhanced its R&D capabilities and achieved the following:
- Increased Flexibility: The SaaS-based iLabPower ELN system offers the flexibility needed to manage a wide variety of experimental data and project workflows.
- Improved Efficiency: The rapid deployment and integration of ELN and PM systems allowed for seamless collaboration and data sharing across projects, reducing time spent on manual data management.
- Enhanced Compliance: The new system ensures full compliance with regulatory requirements, while also improving traceability and data integrity.
- Scalability for Growth: With a platform capable of scaling alongside the company’s growth, Sanyou is well-equipped to handle increasing project complexity and volume.
With a vision of “using innovative biologic drugs to improve the quality of human life” and a mission of “making innovative biologic drug development easy,” Sanyou Biopharmaceuticals continues to drive innovation and breakthroughs in the field. Digital transformation will undoubtedly empower Sanyou to launch cutting-edge technologies, products, services, and solutions with even greater speed and impact.
